LifeScan Glucose Monitoring Line Enhancements To Debut At ADA Meeting
This article was originally published in The Gray Sheet
Executive Summary
LifeScan blood glucose monitoring product line enhancements slated to debut at the American Diabetes Association scientific sessions in San Diego June 19-22 include improvements to existing meters, test strips and software, as well as a new Penlet Plus lancing device that the Johnson & Johnson subsidiary hopes will build on its leadership of the estimated $1-1.5 bil. U.S. blood glucose monitoring market.